Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Endocrine testing industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Test type trends
2.5 Technology trends
2.6 End-use trends
Chapter 3 Endocrine Testing Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of diabetes, thyroid, and obesity
3.2.1.2 Rising prevalence of endocrine disorders
3.2.1.3 Supportive government funding initiatives
3.2.1.4 Technological developments
3.2.1.5 Growing awareness of routine health monitoring
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost for the development of testing technologies
3.2.2.2 Lack of awareness in underdeveloped & developing countries
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By technology
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Key market trends
3.8 Technological advancements
3.9 Application potential
3.10 Initiatives landscape
3.11 GAP analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix anaylsis
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Endocrine Testing Market Size and Forecast, By Test Type (USD Million & Units)
5.1 Key trends, by test type
5.2 Human Chorionic Gonadotropin (hCG) Hormone Test
5.3 Luteinizing Hormone (LH) Test
5.4 Progesterone Test
5.5 Thyroid Stimulating Hormone (TSH) Test
5.6 Prolactin Test
5.7 Insulin Test
5.8 Others
Chapter 6 Endocrine Testing Market Size and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 Mass Spectroscopy
6.3 Immunoassay
6.4 Chromatography
6.5 Nucleic Acid Based
6.6 Others
Chapter 7 Endocrine Testing Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Clinical Laboratories
7.4 Diagnostic Centers
7.5 Others
Chapter 8 Endocrine Testing Market Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 Bio-Rad Laboratories, Inc.
9.2 Agilent Technologies, Inc.
9.3 bioMérieux SA
9.4 F. Hoffmann-La Roche Ltd
9.5 Siemens Healthineers
9.6 Abbott Laboratories, Inc.
9.7 DiaSorin S.p.A
9.8 Beckman Coulter, Inc.
9.9 AB Sciex
9.10 Laboratory Corporation of America Holdings
9.11 Quest Diagnostics Incorporated
9.12 Thermo Fischer Scientific
9.13 DH Tech. Dev. Pte. Ltd.
9.14 Biomedical Technologies Limited
9.15 Ortho Clinical Diagnostics
9.16 QIAGEN N.V.
